Advertisement
UK markets close in 2 hours 53 minutes
  • FTSE 100

    8,103.04
    +62.66 (+0.78%)
     
  • FTSE 250

    19,745.25
    +25.88 (+0.13%)
     
  • AIM

    755.80
    +1.11 (+0.15%)
     
  • GBP/EUR

    1.1666
    +0.0021 (+0.18%)
     
  • GBP/USD

    1.2481
    +0.0019 (+0.15%)
     
  • Bitcoin GBP

    51,110.67
    -2,263.03 (-4.24%)
     
  • CMC Crypto 200

    1,362.94
    -19.64 (-1.42%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.28
    +0.47 (+0.57%)
     
  • GOLD FUTURES

    2,338.90
    +0.50 (+0.02%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    18,000.65
    -88.05 (-0.49%)
     
  • CAC 40

    8,029.68
    -62.18 (-0.77%)
     

Teva Pharmaceutical’s Generic Medicines Segment in 2017

Teva Pharmaceutical’s Generic Medicines Segment in 2017

In fiscal 2017, Teva Pharmaceutical Industries’ (TEVA) generic medicines segment reported revenues of $12.3 billion compared to $12 billion in 2016, which was a 2% YoY (year-over-year) growth.